| ASVRX | HWSIX | ASVRX / HWSIX | |
| Total Expense Ratio | 1.58 | 0.99 | 160% |
| Annual Report Gross Expense Ratio | 1.58 | 1.06 | 149% |
| Fund Existence | 16 years | 40 years | - |
| Gain YTD | -13.905 | 2.111 | -659% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 250000 | 1% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.85B | 664M | 579% |
| Annual Yield % from dividends | 0.42 | 1.00 | 42% |
| Returns for 1 year | -14.24 | 1.61 | -887% |
| Returns for 3 years | 0.70 | 18.22 | 4% |
| Returns for 5 years | 4.90 | 45.40 | 11% |
| Returns for 10 years | 16.96 | 58.90 | 29% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IBB | 173.25 | 1.15 | +0.67% |
| iShares Biotechnology ETF | |||
| IPO | 46.89 | 0.04 | +0.09% |
| Renaissance IPO ETF | |||
| SEPM | 31.84 | -0.01 | -0.03% |
| FT Vest U.S. Eq Max Buffr ETF - Sep | |||
| FEPI | 45.99 | -0.90 | -1.92% |
| REX FANG & Innovation Equity Prm Inc ETF | |||
| JULZ | 42.57 | -4.90 | -10.32% |
| Trueshares Structured Outcome July ETF | |||